REFILE-Roche buys U.S. drugmaker Promedior for up to $1.4 bln to get lung drug
November 15, 2019 at 12:18 PM EST
Swiss drugmaker Roche is paying up to $1.4 billion to buy U.S. biotech company Promedior, whose main drug candidate against the lung disease idiopathic pulmonary fibrosis is set to begin late-stage trials, Promedior said on Friday.
